Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Göhring, Gudrun  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
Manukjan G, Ripperger T, Venturini L, Stadler M, Göhring G, Schambach A, Schlegelberger B, Steinemann D. GABP is necessary for stem/progenitor cell maintenance and myeloid differentiation in human hematopoiesis and chronic myeloid leukemia. Stem Cell Res. 2016;16(3):677-681.
Jung-Klawitter S, Wächter S, Hagedorn M, Ebersold J, Göhring G, Opladen T. Generation of 2 iPSC clones from a patient with DNAJC12 deficiency: DHMCi003-A and DHMCi003-B. Stem Cell Res. 2019;36:101402.
Engels L, Olmer R, de la Roche J, Göhring G, Ulrich S, Haller R, Martin U, Merkert S. Generation of a CFTR knock-in reporter cell line (MHHi006-A-1) from a human induced pluripotent stem cell line. Stem Cell Res. 2019;40:101542.
Olmer R, Dahlmann J, Merkert S, Baus S, Göhring G, Martin U. Generation of a NKX2.1 knock-in reporter cell line from human induced pluripotent stem cells (MHHi006-A-2). Stem Cell Res. 2019;39:101492.
Lenz D, Staufner C, Wächter S, Hagedorn M, Ebersold J, Göhring G, Kölker S, Hoffmann GF, Jung-Klawitter S. Generation of an induced pluripotent stem cell (iPSC) line, DHMCi005-A, from a patient with CALFAN syndrome due to mutations in SCYL1. Stem Cell Res. 2019;37:101428.
Fluhr TLeonie, Tabatabaeifar M, Syring H, Göhring G, Schaefer F, Jung-Klawitter S. Generation of an induced pluripotent stem cell line (DHMCi006-A) from a patient with autosomal recessive polycystic kidney disease (ARPKD) carrying a compound heterozygous missense mutation in the fibrocystin encoding PKHD1 gene. Stem Cell Res. 2021;57:102579.
Tabatabaeifar M, Fluhr TLeonie, Syring H, Göhring G, Schaefer F, Jung-Klawitter S. Generation of an induced pluripotent stem cell line (DHMCi007-A) from a patient with autosomal recessive polycystic kidney disease (ARPKD) carrying a homozygous missense mutation in the fibrocystin-encoding PKHD1 gene. Stem Cell Res. 2021;57:102573.
Lenz D, Staufner C, Wächter S, Hagedorn M, Ebersold J, Göhring G, Kölker S, Hoffmann GF, Jung-Klawitter S. Generation of an iPSC line from a patient with infantile liver failure syndrome 2 due to mutations in NBAS: DHMCi004-A. Stem Cell Res. 2019;35:101398.
Usman A, Haase A, Merkert S, Göhring G, Hansmann G, Gall H, Schermuly R, Martin U, Olmer R. Generation of pulmonary arterial hypertension patient-specific induced pluripotent stem cell lines from three unrelated patients with a heterozygous missense mutation in exon 12, a heterozygous in-frame deletion in exon 3 and a missense mutation in exon 1. Stem Cell Res. 2021;55:102488.
Sahabian A, von Schlehdorn L, Drick N, Pink I, Dahlmann J, Haase A, Göhring G, Welte T, Martin U, Ringshausen FC, et al. Generation of two hiPSC clones (MHHi019-A, MHHi019-B) from a primary ciliary dyskinesia patient carrying a homozygous deletion in the NME5 gene (c.415delA (p.Ile139Tyrfs*8)). Stem Cell Res. 2020;48:101988.
Dahlmann J, Sahabian A, Drick N, Haase A, Göhring G, Lachmann N, Ringshausen FC, Welte T, Martin U, Olmer R. Generation of two hiPSC lines (MHHi016-A, MHHi016-B) from a primary ciliary dyskinesia patient carrying a homozygous 5 bp duplication (c.248_252dup (p.Gly85Cysfs*11)) in exon 1 of the CCNO gene. Stem Cell Res. 2020;46:101850.
Drick N, Dahlmann J, Sahabian A, Haase A, Göhring G, Lachmann N, Ringshausen FC, Welte T, Martin U, Olmer R. Generation of two human induced pluripotent stem cell lines (MHHi017-A, MHHi017-B) from a patient with primary ciliary dyskinesia carrying a homozygous mutation (c.7915C > T [p.Arg2639*]) in the DNAH5 gene. Stem Cell Res. 2020;46:101848.
Steinemann D, Göhring G, Schlegelberger B. Genetic instability of modified stem cells - a first step towards malignant transformation?. Am J Stem Cells. 2013;2(1):39-51.
Haase A, Glienke W, Engels L, Göhring G, Esser R, Arseniev L, Martin U. GMP-compatible manufacturing of three iPS cell lines from human peripheral blood. Stem Cell Res. 2019;35:101394.

Pages